Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma

This study has been terminated.
Information provided by (Responsible Party):
Hoffmann-La Roche Identifier:
First received: May 29, 2012
Last updated: October 3, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)